TREATMENT OF INHIBITOR RESISTANT BRAF-MUTANT CANCERS
The disclosure relates to improved methods of treatment of cancer, in particular cancer that is resistant to treatment with MAPK pathway inhibitors, for example has acquired resistance to such MAPK pathway inhibitors. The disclosure provides pharmaceutical compositions for use in such treatment, tre...
Gespeichert in:
Hauptverfasser: | , |
---|---|
Format: | Patent |
Sprache: | eng ; fre |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!